Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...

Mental health conditions such as alcohol use disorder and PTSD could significantly increase risk for liver cancer among ...

Sydney Towle, 26, has documented her journey with rare, aggressive bile duct cancer since she was diagnosed in 2023 ...

Rob Hirst was first diagnosed with pancreatic cancer in 2023. It is estimated to be the third most common cause of cancer ...

Compass Therapeutics, Inc. is rated a Buy with strong cash position and strong data readout by the end of 1H 2026. Read more ...

The number of active commercial cancer centers which are eligible to order and use RenovoCath has increased from five in September 2025 to nine currently and growing with the addition of City of Hope ...

Wits scientists have identified a "microbial watchlist" of bacteria, viruses, fungi and parasites that could cause cancer.

The widows of three Iowa firefighters, along with other first responders, successfully campaigned state legislators to expand ...

A decorated Army veteran who spent more than three decades serving his country is now facing a battle far from the ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany-- 12 January, 2026 -- Boehringer Ingelheim today announced a strategic ...

Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant breakthrough in treatment options.